BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Thomassin L, Armengol-Debeir L, Charpentier C, Bridoux V, Koning E, Savoye G, Savoye-Collet C. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease. World J Gastroenterol 2017; 23(23): 4285-4292 [PMID: 28694669 DOI: 10.3748/wjg.v23.i23.4285]
URL: https://www.wjgnet.com/1007-9327/full/v23/i23/4285.htm
Number Citing Articles
1
Mary-Louise C. Greer, Stuart A. Taylor. Perianal Imaging in Crohn Disease: Current Status With a Focus on MRI, From the AJR Special Series on Imaging of InflammationAmerican Journal of Roentgenology 2022; 218(5): 781 doi: 10.2214/AJR.21.26615
2
Giulio Aniello Santoro, Christian Raymond S. Magbojos, Giovanni Maconi, Iwona Sudoł-Szopińska. Pelvic Floor Disorders2021; : 1003 doi: 10.1007/978-3-030-40862-6_81
3
Viviane Lin, Seyma Gögenur, Frederik Pachler, Tina Fransgaard, Ismail Gögenur. Risk Prediction for Complications in Inflammatory Bowel Disease Surgery: External Validation of the American College of Surgeons’ National Surgical Quality Improvement Program Surgical Risk CalculatorJournal of Crohn's and Colitis 2023; 17(1): 73 doi: 10.1093/ecco-jcc/jjac114
4
Marion Chambaz, Mikael Verdalle-Cazes, Charlotte Desprez, Lucie Thomassin, Cloé Charpentier, Sébastien Grigioni, Laura Armengol-Debeir, Valérie Bridoux, Guillaume Savoye, Céline Savoye-Collet. Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn’s diseaseDigestive and Liver Disease 2019; 51(3): 358 doi: 10.1016/j.dld.2018.12.010
5
Nicolas Richard, Antonin Derinck, Valérie Bridoux, Cloé Charpentier, Céline Savoye Collet, Guillaume Savoye. Which magnetic resonance imaging feature is associated with treatment response in perianal fistulizing Crohn’s disease?Abdominal Radiology 2024; 49(8): 2913 doi: 10.1007/s00261-024-04238-3
6
Ye Ma, Runfeng Zhang, Wei Liu, Yinghao Sun, Jingnan Li, Hong Yang, Hong Lv, Yue Li, Bei Tan, Xiyu Sun, Jiaming Qian, Ji Li. Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s diseaseBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02676-9
7
Xue-Liang Sun, Shi-Yi Chen, Shan-Shan Tao, Li-Chao Qiao, Hong-Jin Chen, Bo-Lin Yang. Optimized timing of using infliximab in perianal fistulizing Crohn's diseaseWorld Journal of Gastroenterology 2020; 26(14): 1554-1563 doi: 10.3748/wjg.v26.i14.1554
8
David A. Schwartz, Laurent Peyrin-Biroulet, Karen Lasch, Shashi Adsul, Silvio Danese. Efficacy and Safety of 2 Vedolizumab Intravenous Regimens for Perianal Fistulizing Crohn’s Disease: ENTERPRISE StudyClinical Gastroenterology and Hepatology 2022; 20(5): 1059 doi: 10.1016/j.cgh.2021.09.028
9
Xiaohan Yan, Mingming Zhu, Qi Feng, Yunqi Yan, Jiangchen Peng, Xitao Xu, Antao Xu, Zhihua Ran. Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imagingGastroenterology Report 2019; 7(1): 50 doi: 10.1093/gastro/goy036
10
Pankaj Garg, Vipul D. Yagnik, Baljit Kaur, Geetha R. Menon, Sushil Dawka. Role of MRI to confirm healing in complex high cryptoglandular anal fistulas: long‐term follow‐up of 151 casesColorectal Disease 2021; 23(9): 2447 doi: 10.1111/codi.15695
11
Tanya Lee, Eric Yong, Nik S Ding. Radiological outcomes in perianal fistulizing Crohn's disease: A systematic review and meta‐analysisJGH Open 2020; 4(3): 340 doi: 10.1002/jgh3.12295
12
Sudheer K Vuyyuru, Virginia Solitano, Siddharth Singh, Jurij Hanzel, John K Macdonald, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath. Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic ReviewJournal of Crohn's and Colitis 2024; 18(6): 836 doi: 10.1093/ecco-jcc/jjad214
13
Firas Rinawi, Mary-Louise C. Greer, Thomas Walters, Peter C. Church, Amanda Ricciuto, Jacob C. Langer, Anne M Griffiths. Anti TNF treatment of complex perianal fistulas in children without luminal Crohn's disease: Is it an option?Journal of Pediatric Surgery 2022; 57(11): 569 doi: 10.1016/j.jpedsurg.2022.03.031
14
UEG Week 2018 Poster PresentationsUnited European Gastroenterology Journal 2018; 6(S8) doi: 10.1177/2050640618792819
15
Arshdeep Singh, Chandan Kakkar, Shreya Garg, Kirti Arora, Vandana Midha, Ramit Mahajan, Satpal Singh Virk, Narender Pal Jain, Dharmatma Singh, Kriti Sood, Ashish Tripathi, Dhruv Gupta, Ishita Gupta Kaushal, Ritu Dhawan Galhotra, Kavita Saggar, Ajit Sood. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn’s disease: A cohort study from northern IndiaIndian Journal of Gastroenterology 2023; 42(5): 668 doi: 10.1007/s12664-023-01399-9
16
Nicola S. Fearnhead. Inflammatory Bowel Disease Nursing Manual2019; : 173 doi: 10.1007/978-3-319-75022-4_20
17
Parul Tandon, Glara Gaeun Rhee, David Schwartz, Jeffrey D. McCurdy. Strategies to Optimize Anti-tumor Necrosis Factor Therapy for Perianal Fistulizing Crohn’s Disease: A Systematic ReviewDigestive Diseases and Sciences 2019; 64(11): 3066 doi: 10.1007/s10620-019-05635-1
18
Tanya Lee, Michael A Kamm, Sally Bell, Mark Lust, Steve Brown, Ola Niewiadomski, Chamara Basnayake, Emily Wright, Basil D'Souza, Rodney Woods, Shu Chen Wei, William Connell, Alexander Thompson, Eric Yong, Nik Sheng Ding. Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic eraJGH Open 2021; 5(2): 235 doi: 10.1002/jgh3.12475
19
Laura Sirmai, Anne-Laure Pelletier, Nathalie Gault, Camille Zallot, Guillaume Bouguen, Dominique Bouchard, Pascale Roland Nicaise, Marine Peyneau, Sandrine Sironneau, Marcelo De Carvalho Bittencourt, Antoine Petitcollin, Pedro Fernandez, Xavier Roblin, Laurent Siproudhis, Laurent Abramowitz. Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional studyWorld Journal of Gastroenterology 2022; 28(9): 961-972 doi: 10.3748/wjg.v28.i9.961
20
Bénédicte Caron, Ferdinando D’Amico, Silvio Danese, Laurent Peyrin-Biroulet. Endpoints for Perianal Crohn’s Disease Trials: Past, Present and FutureJournal of Crohn's and Colitis 2021; 15(8): 1387 doi: 10.1093/ecco-jcc/jjab026
21
Jeffrey D. McCurdy, Javeria Munir, Simon Parlow, Jacqueline Reid, Russell Yanofsky, Talal Alenezi, Joseph Meserve, Brenda Becker, Zubin Lahijanian, Anas Hussam Eddin, Ranjeeta Mallick, Tim Ramsay, Greg Rosenfeld, Ali Bessissow, Talat Bessissow, Vipul Jairath, Siddharth Singh, David H. Bruining, Blair Macdonald. Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter StudyClinical Gastroenterology and Hepatology 2024; 22(5): 1058 doi: 10.1016/j.cgh.2023.12.006
22
Etienne Buscail, Guillaume Le Cosquer, Fabian Gross, Marine Lebrin, Laetitia Bugarel, Céline Deraison, Nathalie Vergnolle, Barbara Bournet, Cyrielle Gilletta, Louis Buscail. Adipose-Derived Stem Cells in the Treatment of Perianal Fistulas in Crohn’s Disease: Rationale, Clinical Results and PerspectivesInternational Journal of Molecular Sciences 2021; 22(18): 9967 doi: 10.3390/ijms22189967
23
Fabian Juliao-Baños, Carlos Fernando Grillo A, Luis Fernando Pineda Ovalle, William Otero Regino. , María Teresa Galiano de Sánchez. , Rafael García Duperly. , María Teresa Vallejo O. , Marcela Torres Amaya. . Guía de práctica clínica para el tratamiento de la enfermedad de Crohn en población adulta Revista Colombiana de Gastroenterología 2020; 35(Supl. 2): 63 doi: 10.22516/25007440.637
24
Nadia Fathallah, Cosmin Cristea, Hélène Beaussier, Sonia Khirani, Vincent de Parades. Infliximab for Anoperineal Lesions in Crohn's Disease: Remission Appears to be Based on Rapid Combination Therapy at High DosesJournal of Coloproctology 2022; 42(02): 126 doi: 10.1055/s-0041-1739549
25
Wan-Ting Cao, Rong Huang, Ke-Fang Jiang, Xue-Hui Qiao, Jing-Jing Wang, Yi-Hong Fan, Yi Xu. Predictive value of blood concentration of biologics on endoscopic inactivity in inflammatory bowel disease: A systematic reviewWorld Journal of Gastroenterology 2021; 27(9): 886-907 doi: 10.3748/wjg.v27.i9.886
26
Nahla Azzam, Othman Alharbi, Majid Almadi, Abdulrahman Aljebreen, Turki AlAmeel, Mohammed Alabbas, Salman Bahammam, Ahmed Bashmail, Yasser Alomar, Mahmoud Mosli. Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn’s disease treated with antitumor necrosis factor-alpha agents based on Parks’ classificationEuropean Journal of Gastroenterology & Hepatology 2020; 32(2): 187 doi: 10.1097/MEG.0000000000001634
27
Torsten Kucharzik, Jeroen Tielbeek, Dan Carter, Stuart A Taylor, Damian Tolan, Rune Wilkens, Robert V Bryant, Christine Hoeffel, Isabelle De Kock, Christian Maaser, Giovanni Maconi, Kerri Novak, Søren R Rafaelsen, Martina Scharitzer, Antonino Spinelli, Jordi Rimola. ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2022; 16(4): 523 doi: 10.1093/ecco-jcc/jjab180
28
Konstantinos Papamichael, Adam S Cheifetz. Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapyWorld Journal of Gastroenterology 2017; 23(34): 6197-6200 doi: 10.3748/wjg.v23.i34.6197
29
Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu. Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of ViewAnnals of Coloproctology 2021; 37(1): 5 doi: 10.3393/ac.2021.02.08